Higher baseline interleukin-1β and TNF-α hamper antidepressant response in major depressive disorder-Reference-Cited by-同舟云学术

Higher baseline interleukin-1β and TNF-α hamper antidepressant response in major depressive disorder

Published:2021-01 Issue: Volume:42 Page:35-44
ISSN:0924-977X
Container-title:European Neuropsychopharmacology
language:en
Short-container-title:European Neuropsychopharmacology

Author:

Benedetti Francesco,Poletti Sara,Vai Benedetta,Mazza Mario Gennaro,Lorenzi Cristina,Brioschi Silvia,Aggio Veronica,Branchi Igor,Colombo Cristina,Furlan Roberto,Zanardi Raffaella

Funder

European Commission

Publisher

Elsevier BV

Subject

Pharmacology (medical),Biological Psychiatry,Psychiatry and Mental health,Clinical Neurology,Neurology,Pharmacology

Reference58 articles.

1. Bootstrap enhanced penalized regression for variable selection with neuroimaging data;Abram;Front. Neurosci.,2016

2. Low-grade inflammation as a predictor of antidepressant and anti-inflammatory therapy response in MDD patients: a systematic review of the literature in combination with an analysis of experimental data collected in the EU-Moodinflame consortium;Arteaga-Henríquez;Front. Psychiatry,2019

3. Responder and nonresponder patients exhibit different peripheral transcriptional signatures during major depressive episode;Belzeaux;Transl. Psychiatry,2012

4. Effect of catechol-O-methyltransferase Val(108/158)Met polymorphism on antidepressant efficacy of fluvoxamine;Benedetti;Eur. Psychiatry,2010

5. Inflammatory cytokines influence measures of white matter integrity in bipolar disorder;Benedetti;J. Affect. Disord.,2016

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multimodal brain-derived subtypes of Major depressive disorder differentiate patients for anergic symptoms, immune-inflammatory markers, history of childhood trauma and treatment-resistance;European Neuropsychopharmacology;2024-08

2. Blackberry extract prevents lipopolysaccharide-induced depressive-like behavior in female mice: implications for redox status, inflammation, and brain enzymes;Nutritional Neuroscience;2024-06-11

3. Inflammatory mediators in major depression and bipolar disorder;Translational Psychiatry;2024-06-08

4. Low-dose interleukin 2 antidepressant potentiation in unipolar and bipolar depression: Safety, efficacy, and immunological biomarkers;Brain, Behavior, and Immunity;2024-05

5. Post-COVID Trajectory of Pentraxin 3 Plasma Levels Over 6 Months and Their Association with the Risk of Developing Post-Acute Depression and Anxiety;CNS Drugs;2024-04-24